-
Mashup Score: 0
Learn about the Live SA-CME sessions at the 2022 ASTRO Annual Meeting
Source: www.astro.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Andrée Dutreix (AD) Fellowship Position For A Medical Physicist In 2023-2024 - EORTC - 2 year(s) ago
Skip to content EORTC promotes multidisciplinary cancer research in Europe. EORTC research is conducted in over 300 university hospitals in 32 countries. Its network of investigators comprises more than 2500 scientists and clinicians collaborating in 20 multidisciplinary groups. The European Organisation…
Source: EORTCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📢 EORTC is looking for a #medphys to join its HQ in #Brussels. A one-year research #fellowship renewable to a maximum of 3 years with the possibility of a #PhD. Interested in #ClinicalTrials and #radonc? 👉 https://t.co/ZLJNS6lVnS #WorkWithUs #Jobs #Career https://t.co/Di0iFP0QMo
-
-
Mashup Score: 0
Benjamin H. Lowentritt, MD, FACS, Details Rationale for an Analysis Assessing How Clinical Factors Influence 18F-rhPSMA-7.3 Detection in Suspected Recurrent Prostate CancerNovember 11, 2022The goal of the analysis of the phase 3 SPOTLIGHT trial was to evaluate how clinical factors impact 18F-rhPSMA-7.3 detection rates in a population of patients with suspected recurrent prostate cancer, according…
Source: www.cancernetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Read/view all #ASTRO22 #cancer studies covered by @CancerNetwrk https://t.co/JQ3pHh6AIC #radonc #MedPhys #RadBio https://t.co/1vZfDQoPdX
-
-
Mashup Score: 2
The American Society for Radiation Oncology presented the ASTRO Gold Medal to two of its members. Wendell R. Lutz, PhD, FASTRO, and Timothy R. Williams, MD, FASTRO, received their medals during a ceremony at this year’s ASTRO Annual Meeting, held in San Antonio.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ICYMI: American Society for Radiation Oncology honors two Gold Medal recipients. https://t.co/aVpRo7CziV #ASTRO22 @ASTRO_org #radonc #medphys #HemOnc #OncAlert #MedEd
-
-
Mashup Score: 22023 ACR Med Phys Grad Scholarship Application - 2 year(s) ago
The ACR is offering a scholarship for a medical physics graduate student to attend ACR’s Annual Meeting on May 6 – 10, 2023. Applications must be submitted no later than December 6, 2022 . For more information visit the Scholarships and Internships page or email MESO .
Source: acrmemberservices.wufoo.comCategories: Latest Headlines, RadiologyTweet-
Hey #MedPhys grad students! Applications are now open for our #MedicalPhysics Graduate Student Scholarship. Attend #ACR2023 for free this May, network with colleagues and help shape our member-driven organization. Apply by 12/6! https://t.co/Z1L6sq6Yb6 https://t.co/L8zkZVdIwv
-
-
Mashup Score: 1Machine-learning approach using step counts predicts hospitalization during radiotherapy - 2 year(s) ago
An artificial intelligence model appeared to predict the likelihood of unplanned hospitalizations during chemoradiation therapy among a cohort of patients with various cancer types.The results, presented at American Society for Radiation Oncology Annual Meeting, showed the model, which used daily step counts measured through wearable devices as a proxy to monitor patients’ health, provided
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Machine-learning approach using step counts predicts hospitalization during radiotherapy. https://t.co/paduwO2SqJ #ASTRO22 @ASTRO_org #radonc #medphys #HemOnc #OncAlert #MedEd
-
-
Mashup Score: 2Hypofractionated radiation therapy ‘new standard of care’ for high-risk prostate cancer - 2 year(s) ago
Men with high-risk prostate cancer who received a shorter course of radiation therapy had similar survival and recurrence rates as those who received a longer, standard radiation therapy course, phase 3 trial results showed.Final data from the randomized Prostate Cancer Study 5 — presented at American Society for Radiation Oncology Annual Meeting — revealed the two regimens had
Source: www.healio.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @HemOncToday: NEW STANDARD OF CARE: Hypofractionated radiation therapy for high-risk prostate cancer. https://t.co/aA24RLTwde #ASTRO22…
-
NEW STANDARD OF CARE: Hypofractionated radiation therapy for high-risk prostate cancer. https://t.co/aA24RLTwde #ASTRO22 @ASTRO_org #radonc #medphys #HemOnc #OncAlert #MedEd @mcgillu #prostatecancer
-
-
Mashup Score: 2Hypofractionated whole-breast irradiation safe, effective for certain early breast cancers - 2 year(s) ago
A 3-week course of hypofractionated whole-breast radiation therapy appeared as safe and effective as a conventional treatment course among patients with early-stage breast cancer at high risk for recurrence.The findings, presented at American Society for Radiation Oncology Annual Meeting, showed the addition of concurrent tumor bed boost to hypofractionated radiation therapy following lumpectomy
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
SAFE & EFFECTIVE: Hypofractionated whole-breast irradiation for certain early #breastcancers. https://t.co/LHY8uw8cC4 #BreastCancerAwarenessMonth #ASTRO22 @ASTRO_org #radonc #medphys #HemOnc #OncAlert #MedEd @GenesisCareUS
-
-
Mashup Score: 2
The addition of stereotactic body radiation therapy to sorafenib extended OS among patients with advanced hepatocellular carcinoma, results of the randomized phase 3 NRG Oncology/RTOG 1112 trial showed. Data from the study — presented at American Society for Radiation Oncology Annual Meeting — revealed that radiation before sorafenib also delayed tumor progression without compromising
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Adding radiation therapy to #sorafenib extends survival in advanced liver cancer. https://t.co/pu5uhCTsIT #ASTRO22 @ASTRO_org #radonc #medphys #HemOnc #OncAlert #MedEd #livercancer #radiation #Nexavar @BayerUS
-
-
Mashup Score: 0Sexual health assessment far less common for women vs. men undergoing cancer brachytherapy - 2 year(s) ago
Assessment of sexual function occurred far less often among women undergoing brachytherapy for cervical cancer than men who received the internal radiotherapy for prostate cancer, according to results of a retrospective analysis.The findings, presented at American Society for Radiation Oncology Annual Meeting, showed stark differences in the percentages of women vs. men asked about sexual
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
WOMEN VS. MEN: Sexual health assessment far less common for women undergoing cancer #brachytherapy. https://t.co/EeztS2H9Yq #womenshealth #menshealth #cancer #ASTRO22 @ASTRO_org #radonc #medphys #HemOnc #OncAlert #MedEd
-
Deadline alert: Claim your #ASTRO22 SA-CME credits by December 1. Physicists and dosimetrists have until December 1, 2022, to claim CAMPEP and MDCB credits. Learn how to claim your credits here: https://t.co/PyRX8KaHO0 #MedPhys https://t.co/ZVkoYggZL4